Navigation Links
EraGen Biosciences Ships SARS Diagnostic Test in Record Time

MADISON, Wis., April 30 EraGen Biosciences, Inc. announced today that it has developed a new SARS specific assay test using their proprietary Gene-Code(TM) technology. The test is now in the hands of USAMRIID (US Army Medical Research Institute of Infectious Diseases) and is being shipped to WHO Central Public Health Laboratory (UK) and the Brit......

Full article >>> sequenced to date.......

Full article >>>
'"/>

Source:wistechnology.com By Mike Klein 04/30/03


Related biology technology :

1. EraGen set to highlight diagnostic products at BIO
2. EraGen diagnostic passes UW tests, could quickly detect bird flu
3. EraGen lands $12 million venture round
4. EraGen gets $250,000 state loan to revamp manufacturing facility
5. EraGen strikes big distribution deal; Berbee buys again
6. EraGen cystic fibrosis test to be distributed worldwide through Bayer
7. EraGens SARS test validated by Chinese agency
8. EraGen collaborates with Emory University on HIV detection system
9. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
10. Promega and EraGen sign technology licensing agreement
11. EraGens Revolutionary Genomic-Based Technologies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... 2017  Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, announced ... showed that aerosolized KL4 surfactant reduced lung inflammation ... animal model. The Company believes that these preclinical ... that supports the role of KL4 surfactant as ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 /PRNewswire/ ... their $7M Series B financing, adding an additional $3M ... led by Mesa Verde Venture Partners and other strategic ... be directed towards further accelerating commercial adoption of their ... profiling test and expanding the Paradigm cancer registry. ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive search firm, ... Officer with GenePeeks. Matt is a veteran life sciences and molecular diagnostics ... company focused on identifying inherited disease risk in future generations. In his new ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. („TRIANNI") ... Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung der ... führenden Plattform für die Entdeckung monoklonaler Antikörper. ... neuartiges chimäres Gensegmentdesign aus, das Janssen den ... Antikörpern bietet und das für die schelle Isolierung ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent ... availability of a new report, Sensors for Robotics: Technologies, Markets ... ... ... IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
Breaking Biology News(10 mins):